You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (244)

Journals (0)

1-10 of 244 results for programmed death-ligand 1 inhibitor

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Combination therapy with dendritic cell vaccine and programmed death ligand 1 immune checkpoint inhibitor for hepatocellular carcinoma in an orthotopic mouse model

Open access

Research article

First published 2020

Combination therapy with dendritic cell vaccine and programmed death ligand 1 immune checkpoint inhibitor for hepatocellular carcinoma in an orthotopic mouse model

Chiao-Fang Teng, Ting Wang, Tzu-Hua Wu [...]

Therapeutic Advances in Medical Oncology

Select article: Programmed death-1 or programmed death ligand-1 inhibitors? A meta-analysis of differential efficacy as compared to chemotherapy in advanced non-small cell lung cancer

Retricted access

Review article

First published 2021-3

Programmed death-1 or programmed death ligand-1 inhibitors? A meta-analysis of differential efficacy as compared to chemotherapy in advanced non-small cell lung cancer

Hakan Bozcuk, Mehmet Artaç, Hasan Mutlu [...]

Journal of Oncology Pharmacy Practice

Select article: Survival Outcomes and Safety of Programmed Cell Death/Programmed Cell Death Ligand 1 Inhibitors for Unresectable Hepatocellular Carcinoma: Result From Phase III Trials

Open access

Research article

First published 2022-4

Survival Outcomes and Safety of Programmed Cell Death/Programmed Cell Death Ligand 1 Inhibitors for Unresectable Hepatocellular Carcinoma: Result From Phase III Trials

Linyan Zeng, Junwei Su, Wenqi Qiu [...]

Cancer Control

Select article: To do or not to do: A concise update of current clinical controversies in immune checkpoint blockade

Retricted access

Research article

First published 2019-4

To do or not to do: A concise update of current clinical controversies in immune checkpoint blockade

Clement Chung

Journal of Oncology Pharmacy Practice

Select article: A case of drug-induced bullous pemphigoid secondary to immunotherapy treated with upadacitinib: A case report

Open access

Case report

First published 2023

A case of drug-induced bullous pemphigoid secondary to immunotherapy treated with upadacitinib: A case report

Louise M Gresham, Mark G Kirchhof

Sage Open Medical Case Reports

Select article: Immune-related dissociated response as a specific atypical response pattern in solid tumors with immune checkpoint blockade

Open access

Research article

First published 2022

Immune-related dissociated response as a specific atypical response pattern in solid tumors with immune checkpoint blockade

Yaping Guan, Dongfeng Feng, Beibei Yin [...]

Therapeutic Advances in Medical Oncology

Select article: Thyroiditis While Receiving Programmed Death Ligand 1 (PD-L1) Inhibitor Therapy for Nonthyroid Cancers Is Associated with Improved Overall Survival

Retricted access

Research article

First published 2020-02

Thyroiditis While Receiving Programmed Death Ligand 1 (PD-L1) Inhibitor Therapy for Nonthyroid Cancers Is Associated with Improved Overall Survival

Trevor E. Angell

Clinical Thyroidology®

Select article: Association between plasma somatic copy number variations and response to immunotherapy in patients with programmed death-ligand 1-negative non-small cell lung cancer

Open access

Research article

First published 2022-4

Association between plasma somatic copy number variations and response to immunotherapy in patients with programmed death-ligand 1-negative non-small cell lung cancer

Xiaochen Zhang, Yina Wang, Jingjing Xiang [...]

Journal of International Medical Research

Select article: Correction notice to “Combination therapy with dendritic cell vaccine and programmed death ligand 1 immune checkpoint inhibitor for hepatocellular carcinoma in an orthotopic mouse model”

Open access

Correction

First published 2021

Correction notice to “Combination therapy with dendritic cell vaccine and programmed death ligand 1 immune checkpoint inhibitor for hepatocellular carcinoma in an orthotopic mouse model”

Chiao-Fang Teng, Ting Wang, Tzu-Hua Wu [...]

Therapeutic Advances in Medical Oncology

Select article: Clinical Experience of External Application of Clearing Heat and Removing Dampness in Relieving Grade 2 to 3 Rash Caused by Programed Cell Death Protein 1 (PD-1)/Programed Cell Death Ligand 1 (PD-L1) Inhibitors: A Single-Center Retrospective Study

Open access

Research article

First published 2024

Clinical Experience of External Application of Clearing Heat and Removing Dampness in Relieving Grade 2 to 3 Rash Caused by Programed Cell Death Protein 1 (PD-1)/Programed Cell Death Ligand 1 (PD-L1) Inhibitors: A Single-Center Retrospective Study

Shu-yi Chen, Fang-min Zhao, Rui Yu [...]

Integrative Cancer Therapies

1
2
3
•••
25
10 / page

Article type

Publication date

Subjects

Access